Literature DB >> 31981674

Effects of acute versus recurrent insulin-induced hypoglycemia on ventromedial hypothalamic nucleus metabolic-sensory neuron AMPK activity: Impact of alpha1-adrenergic receptor signaling.

Karen P Briski1, Santosh K Mandal2, Khaggeswar Bheemanapally2, Mostafa M H Ibrahim2.   

Abstract

Mechanisms that underlie metabolic sensor acclimation to recurring insulin-induced hypoglycemia (RIIH) are unclear. Norepinephrine (NE) regulates ventromedial hypothalamic nucleus (VMN) gluco-stimulatory nitric oxide (NO) and gluco-inhibitory γ-aminobutryic acid (GABA) neuron signaling. Current research addressed the hypothesis that during RIIH, NE suppresses 5'-AMP-activated protein kinase (AMPK) reactivity in both populations and impedes counter-regulation. The brain is postulated to utilize non-glucose substrates, e.g. amino acids glutamine (Gln), glutamate (Glu), and aspartate (Asp), to produce energy during hypoglycemia. A correlated aim investigated whether NE controls pyruvate recycling pathway marker protein (glutaminase, GLT; malic enzyme, ME-1) expression in either metabolic-sensory cell population. Male rats were injected subcutaneously with vehicle or insulin on days 1-3, then pretreated on day 4 by intracerebroventricular delivery of the alpha1-adrenergic receptor (α1-AR) reverse-agonist prazocin (PRZ) or vehicle before final insulin therapy. PRZ prevented acute hypoglycemic augmentation of AMPK activation in each cell group. Antecedent hypoglycemic repression of sensor activity was reversed by PRZ in GABA neurons. During RIIH, nitrergic neurons exhibited α1-AR - dependent up-regulated GLT and α2-AR profiles, while GABA cells showed down-regulated α1-AR. LC-ESI-MS analysis documented a decline in VMN Glu, Gln, and Asp concentrations during acute hypoglycemia, and habituation of the former two profiles to RIIH. PRZ attenuated glucagon and corticosterone secretion during acute hypoglycemia, but reversed decrements in output of both hormones during RIIH. Results implicate adjustments in impact of α1-AR signaling in repressed VMN metabolic-sensory AMPK activation and counter-regulatory dysfunction during RIIH. Antecedent hypoglycemia may up-regulate NO neuron energy yield via α1-AR - mediated up-regulated pyruvate recycling.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aspartate; Neuronal nitric oxide synthase; Prazocin; Recurrent insulin-induced hypoglycemia; Ventromedial hypothalamic nucleus

Year:  2020        PMID: 31981674      PMCID: PMC7332013          DOI: 10.1016/j.brainresbull.2020.01.013

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  30 in total

1.  Sex differences in forebrain estrogen receptor regulation of hypoglycemic patterns of counter-regulatory hormone secretion and ventromedial hypothalamic nucleus glucoregulatory neurotransmitter and astrocyte glycogen metabolic enzyme expression.

Authors:  A S M Hasan Mahmood; M M Uddin; M M H Ibrahim; S K Mandal; H N Alhamami; K P Briski
Journal:  Neuropeptides       Date:  2018-10-26       Impact factor: 3.286

2.  Recurrent insulin-induced hypoglycemia causes site-specific patterns of habituation or amplification of CNS neuronal genomic activation.

Authors:  S A Paranjape; K P Briski
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

3.  Local lactate perfusion of the ventromedial hypothalamus suppresses hypoglycemic counterregulation.

Authors:  Monica A Borg; William V Tamborlane; Gerald I Shulman; Robert S Sherwin
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

4.  Hindbrain dorsal vagal complex AMPK controls hypothalamic gluco-regulatory transmitter and counter-regulatory hormone responses to hypoglycemia.

Authors:  Santosh K Mandal; Karen P Briski
Journal:  Brain Res Bull       Date:  2018-11-24       Impact factor: 4.077

5.  Hindbrain medulla catecholamine cell group involvement in lactate-sensitive hypoglycemia-associated patterns of hypothalamic norepinephrine and epinephrine activity.

Authors:  P K Shrestha; P Tamrakar; B A Ibrahim; K P Briski
Journal:  Neuroscience       Date:  2014-07-30       Impact factor: 3.590

6.  Effect of hypoglycemic encephalopathy upon amino acids, high-energy phosphates, and pHi in the rat brain in vivo: detection by sequential 1H and 31P NMR spectroscopy.

Authors:  K L Behar; J A den Hollander; O A Petroff; H P Hetherington; J W Prichard; R G Shulman
Journal:  J Neurochem       Date:  1985-04       Impact factor: 5.372

7.  Norepinephrine control of ventromedial hypothalamic nucleus glucoregulatory neurotransmitter expression in the female rat: Role of monocarboxylate transporter function.

Authors:  A S M Hasan Mahmood; Santosh K Mandal; Khaggeswar Bheemanapally; Mostafa M H Ibrahim; K P Briski
Journal:  Mol Cell Neurosci       Date:  2019-01-17       Impact factor: 4.314

8.  Hindbrain 5'-Adenosine Monophosphate-activated Protein Kinase Mediates Short-term Food Deprivation Inhibition of the Gonadotropin-releasing Hormone-Luteinizing Hormone Axis: Role of Nitric Oxide.

Authors:  Manita Shakya; Prem K Shrestha; Karen P Briski
Journal:  Neuroscience       Date:  2018-05-07       Impact factor: 3.590

9.  Modulation of β-adrenergic receptors in the ventromedial hypothalamus influences counterregulatory responses to hypoglycemia.

Authors:  Barbara Szepietowska; Wanling Zhu; Owen Chan; Adam Horblitt; James Dziura; Robert S Sherwin
Journal:  Diabetes       Date:  2011-10-19       Impact factor: 9.461

Review 10.  Hypothalamic glucose sensing: making ends meet.

Authors:  Vanessa H Routh; Lihong Hao; Ammy M Santiago; Zhenyu Sheng; Chunxue Zhou
Journal:  Front Syst Neurosci       Date:  2014-12-10
View more
  7 in total

1.  Single-cell multiplex qPCR evidence for sex-dimorphic glutamate decarboxylase, estrogen receptor, and 5'-AMP-activated protein kinase alpha subunit mRNA expression by ventromedial hypothalamic nucleus GABAergic neurons.

Authors:  Md Haider Ali; Ayed A Alshamrani; Prabhat R Napit; Karen P Briski
Journal:  J Chem Neuroanat       Date:  2022-06-27       Impact factor: 3.097

2.  Sex-dimorphic aromatase regulation of ventromedial hypothalamic nucleus glycogen content in euglycemic and insulin-induced hypoglycemic rats.

Authors:  Mostafa M H Ibrahim; Md Main Uddin; Khaggeswar Bheemanapally; Karen P Briski
Journal:  Neurosci Lett       Date:  2020-08-25       Impact factor: 3.046

3.  Sex-dimorphic Rostro-caudal Patterns of 5'-AMP-activated Protein Kinase Activation and Glucoregulatory Transmitter Marker Protein Expression in the Ventrolateral Ventromedial Hypothalamic Nucleus (VMNvl) in Hypoglycemic Male and Female Rats: Impact of Estradiol.

Authors:  Ayed A Alshamrani; Khaggeswar Bheemanapally; Abdulrahman Alhamyani; Md Haider Ali; Prabhat R Napit; Md Main Uddin; A S M Hasan Mahmood; Mostafa M H Ibrahim; Karen P Briski
Journal:  J Mol Neurosci       Date:  2020-11-24       Impact factor: 3.444

4.  Ventromedial hypothalamic nucleus glycogen regulation of metabolic-sensory neuron AMPK and neurotransmitter expression: role of lactate.

Authors:  Khaggeswar Bheemanapally; Mostafa M H Ibrahim; Ayed Alshamrani; Karen P Briski
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-04-07       Impact factor: 3.210

5.  Neuroestradiol regulation of ventromedial hypothalamic nucleus 5'-AMP-activated protein kinase activity and counterregulatory hormone secretion in hypoglycemic male versus female rats.

Authors:  Md Main Uddin; Karen P Briski
Journal:  AIMS Neurosci       Date:  2020-12-16

6.  Glycogen Phosphorylase Isoform Regulation of Ventromedial Hypothalamic Nucleus Gluco-Regulatory Neuron 5'-AMP-Activated Protein Kinase and Transmitter Marker Protein Expression.

Authors:  Md Main Uddin; Mostafa M H Ibrahim; Karen P Briski
Journal:  ASN Neuro       Date:  2021 Jan-Dec       Impact factor: 4.146

Review 7.  Norepinephrine Regulation of Ventromedial Hypothalamic Nucleus Metabolic-Sensory Neuron 5'-AMP-Activated Protein Kinase Activity: Impact of Estradiol.

Authors:  A S M Hasan Mahmood; Md Main Uddin; Mostafa M H Ibrahim; Karen P Briski
Journal:  Int J Mol Sci       Date:  2020-03-16       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.